Detalhe da pesquisa
1.
Desensitization protocol to lenalidomide: An effective and safe treatment modality for delayed hypersensitivity-induced rash in patients with multiple myeloma.
Eur J Haematol
; 110(4): 407-413, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36565290
2.
Risk factors and outcomes of COVID-19 in adult patients with hematological malignancies: A single-center study showing lower than expected rates of hospitalization and mortality.
Eur J Haematol
; 111(1): 135-145, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37096337
3.
Monitoring Minimal Residual Disease in RUNX1-Mutated Acute Myeloid Leukemia.
Acta Haematol
; 145(6): 642-649, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35933982
4.
Romidepsin-Bendamustine Combination for Relapsed/Refractory T Cell Lymphoma.
Acta Haematol
; 141(4): 216-221, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30943470
5.
Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the "3 + 7" induction regimen for acute myeloid leukemia.
Am J Hematol
; 90(12): 1159-64, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26435038
6.
Bone marrow blast elimination by the fifth day of 7 + 3 induction is the strongest predictor of potential cure in patients with acute myeloid leukemia younger than 61 years of age: A long-term follow-up of a multi-center prospective study.
Am J Hematol
; 95(1): E3-E5, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31591736
7.
Clonal Myeloid Dysplasia Following CAR T-Cell Therapy: Chicken or the Egg?
Cancers (Basel)
; 15(13)2023 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37444582
8.
MDS-Related Anemia Is Associated with Impaired Quality of Life but Improvement Is Not Always Achieved by Increased Hemoglobin Level.
J Clin Med
; 12(18)2023 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37762806
9.
Rituximab, methotrexate, procarbazine and lomustine (R-MPL) for the treatment of primary Central nervous system lymphoma.
Leuk Lymphoma
; 63(9): 2102-2108, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35491706